These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 36009055)

  • 1. Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders.
    Assogna M; Di Lorenzo F; Martorana A; Koch G
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
    Paterniti I; Cordaro M; Campolo M; Siracusa R; Cornelius C; Navarra M; Cuzzocrea S; Esposito E
    CNS Neurol Disord Drug Targets; 2014; 13(9):1530-41. PubMed ID: 25106636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans.
    Landolfo E; Cutuli D; Petrosini L; Caltagirone C
    Biomolecules; 2022 May; 12(5):. PubMed ID: 35625595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia.
    Assogna M; Casula EP; Borghi I; Bonnì S; Samà D; Motta C; Di Lorenzo F; D'Acunto A; Porrazzini F; Minei M; Caltagirone C; Martorana A; Koch G
    J Alzheimers Dis; 2020; 76(4):1297-1308. PubMed ID: 32623398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
    Paterniti I; Impellizzeri D; Di Paola R; Navarra M; Cuzzocrea S; Esposito E
    J Neuroinflammation; 2013 Jul; 10():91. PubMed ID: 23880066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroglial roots of neurodegenerative diseases: therapeutic potential of palmitoylethanolamide in models of Alzheimer's disease.
    Scuderi C; Steardo L
    CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):62-9. PubMed ID: 23394526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review.
    Petrosino S; Schiano Moriello A
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications.
    Valenza M; Facchinetti R; Steardo L; Scuderi C
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palmitoylethanolamide protects against the amyloid-β25-35-induced learning and memory impairment in mice, an experimental model of Alzheimer disease.
    D'Agostino G; Russo R; Avagliano C; Cristiano C; Meli R; Calignano A
    Neuropsychopharmacology; 2012 Jun; 37(7):1784-92. PubMed ID: 22414817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man.
    Caltagirone C; Cisari C; Schievano C; Di Paola R; Cordaro M; Bruschetta G; Esposito E; Cuzzocrea S;
    Transl Stroke Res; 2016 Feb; 7(1):54-69. PubMed ID: 26706245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution.
    Skaper SD; Facci L; Barbierato M; Zusso M; Bruschetta G; Impellizzeri D; Cuzzocrea S; Giusti P
    Mol Neurobiol; 2015 Oct; 52(2):1034-42. PubMed ID: 26055231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Benefits of Palmitoylethanolamide in Palliation: A Qualitative Systematic Review.
    Davis MP; Behm B; Mehta Z; Fernandez C
    Am J Hosp Palliat Care; 2019 Dec; 36(12):1134-1154. PubMed ID: 31113223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Association of Palmitoylethanolamide with Luteolin Decreases Autophagy in Spinal Cord Injury.
    Siracusa R; Paterniti I; Bruschetta G; Cordaro M; Impellizzeri D; Crupi R; Cuzzocrea S; Esposito E
    Mol Neurobiol; 2016 Aug; 53(6):3783-3792. PubMed ID: 26143261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial Effects of Co-Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism.
    Bertolino B; Crupi R; Impellizzeri D; Bruschetta G; Cordaro M; Siracusa R; Esposito E; Cuzzocrea S
    CNS Neurosci Ther; 2017 Jan; 23(1):87-98. PubMed ID: 27701827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects.
    Scuderi C; Bronzuoli MR; Facchinetti R; Pace L; Ferraro L; Broad KD; Serviddio G; Bellanti F; Palombelli G; Carpinelli G; Canese R; Gaetani S; Steardo L; Steardo L; Cassano T
    Transl Psychiatry; 2018 Jan; 8(1):32. PubMed ID: 29382825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergic Therapeutic Potential of PEA-Um Treatment and NAAA Enzyme Silencing In the Management of Neuroinflammation.
    Casili G; Lanza M; Campolo M; Siracusa R; Paterniti I; Ardizzone A; Scuderi SA; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide.
    Skaper SD; Facci L
    Philos Trans R Soc Lond B Biol Sci; 2012 Dec; 367(1607):3312-25. PubMed ID: 23108549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
    Manzo E; Schiano Moriello A; Tinto F; Verde R; Allarà M; De Petrocellis L; Pagano E; Izzo AA; Di Marzo V; Petrosino S
    Cells; 2021 Feb; 10(2):. PubMed ID: 33672574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel composite formulation of palmitoylethanolamide and quercetin decreases inflammation and relieves pain in inflammatory and osteoarthritic pain models.
    Britti D; Crupi R; Impellizzeri D; Gugliandolo E; Fusco R; Schievano C; Morittu VM; Evangelista M; Di Paola R; Cuzzocrea S
    BMC Vet Res; 2017 Aug; 13(1):229. PubMed ID: 28768536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous fatty acid amide, palmitoylethanolamide, has anti-allodynic and anti-hyperalgesic effects in a murine model of neuropathic pain: involvement of CB(1), TRPV1 and PPARgamma receptors and neurotrophic factors.
    Costa B; Comelli F; Bettoni I; Colleoni M; Giagnoni G
    Pain; 2008 Oct; 139(3):541-550. PubMed ID: 18602217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.